Don Darkin - ResMed Insider

RMD -- USA Stock  

USD 102.69  0.56  0.54%

  President
Mr. Don Darkin is President innovation operations of Resmed Inc. Previously Mr. Darkin was president sleepdisordered breathing strategic business unit a position he began in May 2011 and senior vice president strategic business unit patient interfaces from July 2007 to May 2011. Before these positions Mr. Darkin held several senior roles within ResMed. He joined ResMed in August 1999 as vice president product development. In May 2005 he became director of operations in France for ventilation and subsequently served as vice president business divisions and senior vice president global product development. Before working at ResMed Mr. Darkin served as vice president of operations for Ambri Pty Ltd. Australia and vice president product development for Telectronics Medical Systems Australia and US. Mr. Darkin is identified as an inventor or coinventor on over 80 granted patents worldwide. Mr. Darkin was educated in the UK in mechanical engineering and has further professional management training from University of New South Wales and Massachusetts Institute of Technology.
Age: 61  President Since 2014      
858-836-5000  http://www.resmed.com

Don Darkin Latest Insider Activity

Management Efficiency

The company has Return on Asset of 10.72 % which means that on every $100 spent on asset it made $10.72 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.7 % implying that it generated $15.7 on every 100 dollars invested.
The company has 281.45 M in debt with debt to equity (D/E) ratio of 13.6 . This implies that the company may be unable to create cash to meet all of its financial commitments. ResMed has Current Ratio of 2.05 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

John SweeneyDENTSPLY SIRONA
2017
Rafael TorresVarian Medical Systems
2015
David FloydStryker Corporation
2012
Eric PalmerCigna Corporation
2017
Yin BeckerStryker Corporation
2016
Scott BruderStryker Corporation
2013
Bronwen TaylorStryker Corporation
2013
Glenn BoehnleinStryker Corporation
2016
Viju MenonStryker Corporation
2018
Timothy ScannellStryker Corporation
2018
Albert SterkenburgDENTSPLY SIRONA
2009
Alicia RodriguezAgilent Technologies
N/A
Bijoy SagarStryker Corporation
2014
Michael PhillipsCigna Corporation
2014
Mark BoxerCigna Corporation
2011
Lisa BacusCigna Corporation
2017
Steven BenscoterStryker Corporation
2012
Henrik AncherJensenAgilent Technologies
2013
Katherine OwenStryker Corporation
2007
Spencer SiasVarian Medical Systems
N/A
Clarence VerhoefVarian Medical Systems
2012

Entity Summary

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and is traded on New York Stock Exchange. It employs 5940 people.ResMed (RMD) is traded on New York Stock Exchange in USA. It is located in 9001 Spectrum Center Boulevard and employs 5,940 people.

ResMed Leadership Team

John Wareham, Independent Director
Ronald Taylor, Lead Independent Director
Rob Douglas, President COO
Christopher Roberts, Independent Director
Gary Pace, Independent Director
Chris Roberts, Independent Director
Robert Douglas, Pres and COO
Agnes Lee, Senior Director - Investor Relations
Carol Burt, Independent Director
Rich Sulpizio, Independent Director
Peter Farrell, Non-Executive Chairman of the Board
Jim Hollingshead, President - Americas
Brett Sandercock, CFO and Principal Accounting Officer
Ron Taylor, Lead Independent Director
Don Darkin, President - Sleep-disordered Breathing Strategic Business Unit
Jack Wareham, Independent Director
Anne Reiser, President Europe
Karen Drexler, Director
Raj Sodhi, President ? Software as a Service (SaaS) Business and CTO
David Pendarvis, Chief Admin. Officer, Global General Counsel and Secretary
Richard Sulpizio, Independent Director
Michael Farrell, CEO and Director
Richard McHale, President ? Respiratory Care
Donald Darkin, President ? innovation & operations

Stock Performance Indicators

Did you try this?

Run ETF Directory Now

   

ETF Directory

Find actively-traded Exchange Traded Funds (ETF) from around the world
All  Next Launch ETF Directory
Currently Active Assets on Macroaxis
MSFT   
Purchased over 20 shares of
few hours ago
Traded for 111.0
C   
Purchased over 40 shares of
few hours ago
Traded for 69.648
VTSMX   
Purchased over 40 shares of
few hours ago
Traded for 68.2
OTPBF   
Purchased over 70 shares of
few hours ago
Traded for 40.5
CRM   
Purchased over 20 shares of
few hours ago
Traded for 147.1
Additionally take a look at Your Equity Center. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.
Search macroaxis.com